ND-L02-s0201
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for ND-L02-s0201, covering 2017-05-11 to 2023-12-11. Get the full timeline:
Most recent: Clinical Trial Update: JUNIPER: A Phase 2 Study to Evaluate the Safety, Biological Activity, and PK of ND-L02-s0201 in Subjects With IPF [Phase 2]